X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (306) 306
oncology (278) 278
male (273) 273
index medicus (228) 228
chemotherapy (166) 166
middle aged (158) 158
prostate cancer (145) 145
aged (131) 131
cancer (123) 123
adult (104) 104
treatment outcome (103) 103
metastasis (102) 102
antineoplastic combined chemotherapy protocols - therapeutic use (94) 94
urology & nephrology (85) 85
urology (83) 83
disease-free survival (79) 79
docetaxel (79) 79
prognosis (76) 76
survival (76) 76
hematology, oncology and palliative medicine (67) 67
prostatic neoplasms - pathology (64) 64
care and treatment (63) 63
men (62) 62
female (60) 60
prostatic neoplasms, castration-resistant - drug therapy (60) 60
prostatic neoplasms - drug therapy (59) 59
neoplasm metastasis (54) 54
antineoplastic agents - therapeutic use (52) 52
aged, 80 and over (51) 51
bone neoplasms - secondary (50) 50
prostatic neoplasms, castration-resistant - pathology (49) 49
double-blind (47) 47
prednisone (47) 47
abiraterone acetate (46) 46
double-blind method (45) 45
survival analysis (45) 45
antineoplastic combined chemotherapy protocols - adverse effects (42) 42
neoplasm staging (42) 42
prostate-specific antigen - blood (41) 41
analysis (39) 39
disease progression (39) 39
risk factors (39) 39
therapy (39) 39
kaplan-meier estimate (38) 38
clinical trials (36) 36
retrospective studies (36) 36
research (35) 35
survival rate (34) 34
time factors (34) 34
trial (33) 33
cisplatin (32) 32
mitoxantrone (32) 32
adolescent (31) 31
enzalutamide (31) 31
metastases (30) 30
orchiectomy (30) 30
prostate (30) 30
radiotherapy (30) 30
testicular cancer (30) 30
androgen antagonists - therapeutic use (28) 28
bone neoplasms - drug therapy (28) 28
carcinoma (28) 28
drug administration schedule (28) 28
follow-up studies (28) 28
management (27) 27
proportional hazards models (27) 27
prostatic neoplasms, castration-resistant - mortality (27) 27
abiraterone (26) 26
cancer therapies (26) 26
prostatic neoplasms - mortality (26) 26
taxoids - administration & dosage (26) 26
zoledronic acid (25) 25
antineoplastic agents, hormonal - therapeutic use (24) 24
diagnosis (24) 24
increased survival (24) 24
life sciences (24) 24
prednisone - administration & dosage (24) 24
radical prostatectomy (24) 24
taxoids - therapeutic use (24) 24
testicular neoplasms - pathology (24) 24
germ-cell tumors (23) 23
combined modality therapy (22) 22
breast-cancer (21) 21
denosumab (21) 21
follow-up (21) 21
mitoxantrone plus prednisone (21) 21
phenylthiohydantoin - analogs & derivatives (21) 21
biomarkers, tumor - blood (20) 20
bone metastases (20) 20
castration (20) 20
drug therapy (20) 20
metastatic castration-resistant prostate cancer (20) 20
prospective studies (20) 20
prostatic neoplasms - therapy (20) 20
risk assessment (20) 20
abridged index medicus (19) 19
androgen-deprivation therapy (19) 19
antineoplastic agents - adverse effects (19) 19
dose-response relationship, drug (19) 19
high-dose chemotherapy (19) 19
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 152 - 160
Journal Article
Journal of Information Processing Systems, ISSN 1976-913X, 2017, Volume 13, Issue 2, pp. 370 - 384
Journal Article
JIPS(Journal of Information Processing Systems), ISSN 1976-913X, 2017, Volume 13, Issue 2, p. 370
The image segmentation is the most important operation in an image processing system. It is located at the joint between the processing and analysis of the... 
K-means | Meta-Heuristic | Image | Optimization | SFLA | Unsupervised Segmentation
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 243 - 256
Journal Article
Annals of Oncology, ISSN 0923-7534, 01/2003, Volume 14, Issue 1, pp. 173 - 173
Journal Article
by Gravis, G and Fizazi, K and Joly Lobbedez, F and Oudard, S and Priou, F and Latorzeff, I and Delva, R and Krakowski, I and Laguerre, B and Rolland, F and Theodore, C and Deplanque, G and Ferrero, J. M and Pouessel, D and Mourey, L and Beuzeboc, P and Zanetta, S and Esterni, B and Habibian, M and Soulie, M and Ryan, C. J and Morris, M and Molina, A and Piulats, J. R and De Souza, P and Li, J and Kheoh, T and de Bono, J. S and Larson, S and Griffin, T and Matheny, S and Naini, V and Scher, H. I and Small, E and Basch, E and Logothetis, C. J and Rathkopf, D. E and Smith, M. R and Mainwaring, P. N and Hao, Y and Li, S and Meyers, M and Cleeland, C and Saad, F and Sternberg, C. N and Miller, K and Mulders, P and Chi, K and Hirmand, M and Rathkopf, D and Corn, P. G and Mukherji, D and Harzstark, A. L and Sartor, O. A and Smith, D. C and Tunariu, N and Sweeney, C and Parker, C and Coleman, R. E and Nilsson, S and Vogelzang, N and Lloyd, A. J and Staudacher, K and van Gool, R and Sartor, A. O and Taplin, M and Armstrong, A. J and Selby, B and Yu, E. Y and Ellard, S and Hotte, S. J and Gingerich, J. R and Joshua, A. M and Gleave, M. E and Sonpavde, G and Pond, G. R and Galsky, M. D and Wood, B. A and Wang, S and Paolini, J and Lechuga, M and Michaelson, M. D and Liede, A and Gunther, O and Bennett, B and Wong, S and Pezaro, C and Omlin, A. G and Sandhu, S and Bianchini, D and Cassidy, A. M and Maier, G and Olmos, D and Attard, G and Dixit, S and Tito, J and Afzal, P and Wolff, J. M and Gedamke, M and Li, C and ...
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix294 - ix318
Journal Article
by Ravaud, A and Barrios, C and Anak, O and Pelov, D and Louveau, A and Alekseev, B and M-H, T and Agarwala, S. S and Yalcin, S and Melichar, B and McDermott, D. F and Drake, C. G and Sznol, M and Choueiri, T. K and Powderly, J. D and Smith, D. C and Wigginton, J. M and Kollia, G and Gupta, A and Atkins, M. B and Donskov, F and Michaelson, M. D and Puzanov, I and Davis, M. P and Bjarnason, G. A and Motzer, R. J and Lin, X and Cohen, D. P and Wiltshire, R and Rini, B. I and Oudard, S and Culine, S and Vieillefond, A and Priou, F and Goldwasser, F and Gravis-Mescam, G and Deplanque, G and Machiels, J. P and Beuzeboc, P and Sonpavde, G and Maughan, B and Boucher, K. M and Fougeray, R and Niegisch, G and Wong, Y and Sridhar, S. S and Sternberg, C. N and Bellmunt, J and Booth, C. M and Siemens, D. R and Li, G and Peng, Y and Tannock, I. F and Berman, D. M and Kong, W and Mackillop, W. J and Selle, F and Fizazi, K and Biron, P and Bui, B and Bay, J and Flechon, A and Dubot, C and Caty, A and Burcoveanu, D and Delva, R and de Revel, T and Miclea, J. M and Gaulet, M and Horn, E and Provent, S and Temby, I and Brindel, I and Khalil, J and Gligorov, J and Lotz, J.- P and Quinn, D. I and Hamid, O and Tsao-Wei, D and Hu, J and Pinski, J and Schuckman, A and Daneshmand, S and Groshen, S and Raghavan, D and Korn, C and Massopust, K and Ketchens, C and Aparicio, A. M and Dorff, T. B and Zurita-Saavedra, A and Liu, Y and Lin, Y and Tran, H. T and Pandite, L. N and Heymach, J. V and Cella, D and Kaiser, K and Beaumont, J and Diaz, J and ... and VEG105192 Team and investigators
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix258 - ix293
Journal Article
by Mok, T. S. K and Paz-Ares, L and Wu, Y.-L and Novello, S and Juhasz, E and Aren, O and Sun, Y and Hirsh, V and Smit, E. F and Lathia, C and Ong, T. J and Pena, C and Pivot, X and Romieu, G and Bonnefoi, H and Pierga, J.-Y and Kerbrat, P and Guastalla, J.-P and Lortholary, A and Espie, M and Fumoleau, P and Serin, D and Jacquin, J.-P and Jouannaud, C and Rios, M and Abadie-Lacourtoisie, S and Tubiana-Mathieu, N and Cany, L and Catala, S and Khayat, D and Pauporte, I and Kramar, A and Goldhirsch, A and Piccart, M and Procter, M and De Azambuja, E and Weber, H and Untch, M and Smith, I. E and Gianni, L and Jackisch, C and Cameron, D and Bell, R and Dowsett, M and Gelber, R. D and Leyland-Jones, B and Baselga, J and Baum, M and Vaidya, J. S and Bulsara, M. K and Wenz, F and Tobias, J. S and Eiermann, W and Joseph, D and Pierga, J and Asselain, B and Alsafadi, S and Brain, E and Lerebours, F and Delaloge, S and Gentien, D and Servant, N and Sigal-Zafrani, B and Andre, F and Criscitiello, C and Azim, H. A and Agbor-Tarh, D and Eidtmann, H and Di Cosimo, S and Bradbury, I and Rubio, I. T and Semiglazov, V and Zurawski, B and Allerton, R and Fabi, A and Ciruelos, E and Parikh, R and DeSilvio, M and Santillana, S and Swaby, R and Verma, S and Miles, D and Krop, I and Welslau, M and Pegram, M and Oh, D and Dieras, V and Guardino, E and Fang, L and Lu, M. W and Olsen, S and Blackwell, K and Bachelot, T and Campone, M and Ballester, M. A and Commo, F and Goncalves, A and Levy, C and Ferrero, J and Lacroix, L and ... and on behalf of the TARGIT trialists group
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ixe1 - ixe30
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 417 - 425
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2012, Volume 367, Issue 13, pp. 1187 - 1197
Journal Article